Overview
Emerging infectious diseases are infections that have newly appeared in a population or that are rapidly increasing in incidence or geographic range, together with re-emerging diseases that resurge after a period of decline. They arise from several mechanisms: the appearance of previously unknown pathogens, the spread of agents into new regions or hosts, the re-emergence of established diseases through drug resistance or lapses in control, and the spillover of zoonotic organisms from animal reservoirs to humans. Drivers include ecological and land-use change, human encroachment on wildlife habitats, global travel and trade, microbial evolution, and, as discussed in the literature, considerations surrounding gain-of-function research and the geopolitics of pathogen study. The category encompasses high-consequence agents such as Ebola virus and pandemic coronaviruses, as well as zoonotic and vector-borne bacteria identified through surveillance of animal hosts and remote communities. Effective response depends on early detection, laboratory capacity including immunoassay and immunogenomic approaches for monitoring infection, robust surveillance, reimbursement and health-system preparedness, and supportive clinical and nutritional care for affected patients. Because environmental change and extreme events can further alter disease risk, the study of emerging infectious diseases integrates microbiology, ecology, epidemiology, and public-health policy to anticipate, prevent, and contain new and resurgent threats.
Research published in this journal
8 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Success for Big Infectious Disease Reimbursement Policy in China
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
The Current Immunoassays and Emerging Immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases
Nutritional Care for Patients with Ebola Virus Disease in Ebola Treatment Units – Past and Current Experiences from Practitioners
Low Seroprevalence of Brucella Spp. among Remote Colombian Communities from the Sierra Nevada De Santa Marta
Perceived Effect of Knowledge Level and Socio-Demographics on COVID-19 Risk Exposure: the Africa Experience
Vulnerabilities in Environment and Health Due to Climate Change and Extreme Hydrological Events: Determinants for Risk Reduction
How this research is being cited
The 8 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Qi Li et al. · 2023 · Biosensors
-
2022 · International Journal of Clinical Virology
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
2022 · International Journal of Clinical Virology
-
Shengzhe Zhou et al. · 2022 · Microbiology Research
-
F. Adzitey et al. · 2022 · Small Animal Advances
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
2022 · Small Animal Advances
A sample of recent works citing this journal's research on Emerging Infectious Diseases, linking to each citing work.